# IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

> **NCT01053949** · PHASE2 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 84 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Pomalidomide
- **DRUG:** Pomalidomide

## Key facts

- **NCT ID:** NCT01053949
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2014-04
- **Final completion:** 2015-04
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2026-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053949, "IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01053949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*